Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB26FV5YP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,898
Award facts
- Contract value 100% obligated
- $7,897.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication, with a ceiling value of $7,897.60. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on October 31, 2025, with an ultimate completion date of November 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 billion and extending through December 2026.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. As a major healthcare solutions provider registered in the System for Award Management, the company demonstrates consistent capability to meet federal procurement requirements through competitive processes. The Ozempic supply under this delivery order supports military healthcare programs, providing a diabetes management medication to meet patient care needs within the Defense Health Agency and related military medical systems. The company's extensive portfolio of federal contract awards reflects its critical role in sustaining pharmaceutical supply chains for DoD and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB26FV5YP?
SPE2DB26FV5YP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FV5YP worth?
The government has obligated $7,898 on SPE2DB26FV5YP.
Is contract SPE2DB26FV5YP an order under another contract?
Yes. SPE2DB26FV5YP is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB26FV5YP competed?
The extent of competition for SPE2DB26FV5YP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award